4-bromo-a-23187 has been researched along with ryanodine in 2 studies
| Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
|---|---|---|---|---|---|
| 63 | 0 | 5 | 2,894 | 3 | 237 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gylfe, E; Hellman, B; Tengholm, A | 1 |
| Atwood, HL; Deitcher, DL; Gu, T; Hewes, RS; Klose, MK; Levitan, ES; Shakiryanova, D; Zhou, Y | 1 |
2 other study(ies) available for 4-bromo-a-23187 and ryanodine
| Article | Year |
|---|---|
Mobilization of Ca2+ stores in individual pancreatic beta-cells permeabilized or not with digitonin or alpha-toxin.
Topics: Adenosine Diphosphate Ribose; Adenosine Triphosphate; Animals; Bacterial Toxins; Caffeine; Calcimycin; Calcium; Calcium-Transporting ATPases; Cell Compartmentation; Cell Membrane Permeability; Cyclic ADP-Ribose; Cytoplasm; Digitonin; Enzyme Inhibitors; Hemolysin Proteins; Inositol 1,4,5-Trisphosphate; Ionophores; Islets of Langerhans; Mice; Mice, Obese; NADP; Organelles; Ryanodine; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2000 |
Presynaptic ryanodine receptor-activated calmodulin kinase II increases vesicle mobility and potentiates neuropeptide release.
Topics: Animals; Animals, Genetically Modified; Caffeine; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Drosophila; Drosophila Proteins; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Green Fluorescent Proteins; Hot Temperature; Larva; Mutation; Neuromuscular Junction; Neuropeptides; Phosphodiesterase Inhibitors; Presynaptic Terminals; Ryanodine; Ryanodine Receptor Calcium Release Channel; Synaptic Vesicles | 2007 |